Business
Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer
WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for
About this update from Rockwell Medical, Inc.
[{"type":"text","content":" WIXOM, Mich.--(BUSINESS WIRE)--\nRockwell Medical, Inc. (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that Heather Hunter has joined the Company as SVP, Chief Corporate Affairs Officer. In this role, Heather will be responsible for the Company’s investor relations, media relations, government affairs, patient advocacy, communications, and branding.\n\n“Heather brings more than two decades of executive leadership, investor relations and communications expertise to Rockwell, with a wealth of experience in the capital markets and a strong network across the financial community,” said Mark Strobeck, Ph.D., President and CEO at Rockwell. “Heather has a demonstrated track record of success elevating corporate brands, developing and implementing corporate strategy, and driving shareholder value. I look forward to working with Heather as we unlock the value of our product portfolio and development expertise and transition our business towards profitability.”\n\n“I am excited for the path that lies ahead at Rockwell and impressed by all that the Company has achieved in its 25+ year history,” said Heather. “Rockwell is at a critical inflection point as the Company works towards profitability and expands its portfolio of offerings for patients suffering from blood disorders and diseases associated with the kidney. I look forward to working with Mark and the rest of the Rockwell team to catalyze and support the Company’s success now and into the future.”\n\nPrior to joining Rockwell, Heather led communications at Venatorx Pharmaceuticals, a private, pre-commercial anti-infectives pharmaceutical company; Safeguard Scientifics (NYSE:SFE), a growth equity investor focused on early- and growth-stage healthcare and technology companies; and W.P. Carey (NYSE:WPC), one of the largest net lease real estate investment trusts. Heather is currently an Advisory Board Member at Journal My Health, a digital health platform designed to empower patients with chronic health conditions to use their data to achieve better health outcomes, and a Managing Director at Golden Seeds, an angel investment firm that funds revenue-stage, women-led and women-founded companies. Heather was named to the Philadelphia Busines...